HomeNDC LookupRxCUI directory › RxCUI 311197

Isosorbide mononitrate 20 MG Oral Tablet — RxCUI 311197

RxNorm drug concept · Semantic clinical drug
RxCUI 311197 Semantic clinical drug · SCD ● Current RxNorm concept 12 FDA products 14 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI311197
Official nameIsosorbide mononitrate 20 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped12
Package NDCs mapped14
Reported Medicaid activity (SDUD)4,302 prescriptions · 25 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Isosorbide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Isosorbide is designed to prevent chest pain (angina) from starting in the first place, not to stop an attack that's already happening. It works by relaxing and widening your blood...
  • What exactly does this medication do — will it stop my chest pain when it happens?
  • Yes, headaches are very common when you first start isosorbide — they happen because the medication widens blood vessels, including in your head. The good news is that headaches us...
  • I keep getting headaches since starting this — is that normal, and will it go away?
📖 Read our full Isosorbide guide →

🕸️ Concept Web — How Isosorbide mononitrate 20 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Isosorbide mononitrate 20 MG Oral Tablet RxCUI 311197

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Isosorbide 6057
    • Isosorbide mononitrate 28004
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Isosorbide Oral Tablet 631993
    • Isosorbide mononitrate Oral Tablet 2647471
    • Isosorbide Oral Product 1159759
    • Isosorbide Pill 1159760
    • Isosorbide mononitrate Oral Product 2662908
    • Isosorbide mononitrate Pill 2662275
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Isosorbide mononitrate 20 MG 381038

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Isosorbide mononitrate 20 MG SCDC · 381038
  • Isosorbide Oral Tablet SCDF · 631993
  • Isosorbide mononitrate Oral Tablet SCDFP · 2647471
  • Isosorbide Oral Product SCDG · 1159759
  • Isosorbide Pill SCDG · 1159760
  • Isosorbide mononitrate Oral Product SCDGP · 2662908
  • Isosorbide mononitrate Pill SCDGP · 2662275

📦 FDA Products & Package NDCs

12 products · 14 package NDCs
14 package NDCs map to RxCUI 311197 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00228-2620-11 100 TABLET in 1 BOTTLE (0228-2620-11) Isosorbide Mononitrate Actavis Pharma, Inc. 1998-10-30
00228-2631-11 100 TABLET in 1 BOTTLE (0228-2631-11) Isosorbide Mononitrate Actavis Pharma, Inc. 1998-10-30
62175-0106-01 100 TABLET in 1 BOTTLE (62175-106-01) isosorbide mononitrate Lannett Company, Inc. 1993-06-30
62175-0107-01 100 TABLET in 1 BOTTLE (62175-107-01) isosorbide mononitrate Lannett Company, Inc. 1993-06-30
62559-0252-01 100 TABLET in 1 BOTTLE (62559-252-01) Isosorbide Mononitrate ANI Pharmaceuticals, Inc. 2026-03-27
62559-0253-01 100 TABLET in 1 BOTTLE (62559-253-01) Isosorbide Mononitrate ANI Pharmaceuticals, Inc. 2026-03-27
63187-0900-30 30 TABLET in 1 BOTTLE (63187-900-30) isosorbide mononitrate Proficient Rx LP 2017-09-01
63187-0900-60 60 TABLET in 1 BOTTLE (63187-900-60) isosorbide mononitrate Proficient Rx LP 2017-09-01
63187-0900-90 90 TABLET in 1 BOTTLE (63187-900-90) isosorbide mononitrate Proficient Rx LP 2017-09-01
64950-0250-01 100 TABLET in 1 BOTTLE (64950-250-01) Isosorbide Mononitrate Genus Lifesciences Inc. 2026-04-09
64950-0251-01 100 TABLET in 1 BOTTLE (64950-251-01) Isosorbide Mononitrate Genus Lifesciences Inc. 2026-04-09
67046-1578-03 30 TABLET in 1 BLISTER PACK (67046-1578-3) isosorbide mononitrate Coupler LLC 2025-09-05
81665-0102-10 100 TABLET in 1 BOTTLE (81665-102-10) isosorbide mononitrate OMNIVIUM PHARMACEUTICALS LLC. 2024-05-02
81665-0103-10 100 TABLET in 1 BOTTLE (81665-103-10) isosorbide mononitrate OMNIVIUM PHARMACEUTICALS LLC. 2024-05-02
Observed labelers: Proficient Rx LP (3) · Actavis Pharma, Inc. (2) · ANI Pharmaceuticals, Inc. (2) · Genus Lifesciences Inc. (2) · Lannett Company, Inc. (2) · OMNIVIUM PHARMACEUTICALS LLC. (2) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.